Eslicarbazepine acetate response in intellectual disability population versus general population.
Jon AllardCharlotte LawthomWilliam HenleyBrendan McleanSharon HudsonPhil TittensorSanjeev RajakulendranShan EllawelaAdrian PaceRichard LaugharnePublished in: Acta neurologica Scandinavica (2020)
Tolerance and Efficacy for ID and 'no ID' people in our data set were similar. Seizure improvement and retention rates were slightly lower than that found in other European data sets, but findings strengthen the evidence for the use of ESL in the ID population.